Researchers find psilocybin improved the anxiety and depression of terminal cancer patients for up to six months. The study is considered a first step in restoring the hallucinogen's respectability. By Thomas H. Maugh II, Los Angeles Times September 7, 2010 The psychedelic drug psilocybin, the active ingredient in “magic mushrooms,” can improve mood and reduce anxiety and depression in terminal cancer patients, Los Angeles researchers reported Monday. A single modest dose of the hallucinogen, whose reputation was severely tarnished by widespread nonmedical use in the psychedelic '60s and ethical lapses by researchers such as Timothy Leary, can improve patients' functioning for as long as six months, allowing them to spend their last days with more peace, researchers said. The research was a pilot study involving only 12 patients, but it is viewed as a first step in restoring the drug to respectability. Get important science news and discoveries delivered to your inbox with our Science & Environment newsletter. Sign up
Name That Celebrity Smile!
Breaking Sports Video
-
Hot Celebrities
-
Tags
api appid art bennyhollywood black celebrity gossip black celebrity news car celeb news Celebrity Gossip Celebrity News context detected Entertainment extraction Gossip Hollywood hollywood-news hollywood update House instagram invalid life live missing Mtv Music music-news national News news article news update Nsfw online Photos Pictures Sex show stars time TMZ update video Videos white Yahoo